The European AIDS Treatment Group (EATG), February 2023 For the first time in humans, a research team has shown that, as early as the first days of infection, HIV is able to create reservoirs where it will hide and persist during antiretroviral therapy. Until now, the scientific community did not know exactly when or how these viral reservoirs—the existence of which is a major obstacle to curing...
National Institute of Allergy and Infectious Diseases (NIAID), July 24, 2017 A nine-year-old South African child who was diagnosed with HIV infection at one month of age and received anti-HIV treatment during infancy has suppressed the virus without anti-HIV drugs for eight and a half years, scientists reported today at the 9th IAS Conference on HIV Science in Paris. This case appears to be the...
PBS Newshour, December 15, 2016 at 11:00 AM EST A new small-scale human trial of the promising “shock and kill” treatment is starting this week in New York and two sister sites, in Germany and Denmark. Another small human study will start in January, followed by a larger human shock and kill trial in June. The HIV research community is increasingly optimistic about this approach to eradicating...
Slate, January 27 2016 While progress toward a vaccine and even a functional cure for HIV has accelerated in recent years, a major obstacle has been the “viral reservoir”—locations and cell types in a body where the virus can persist at very low levels even when treatment has succeeded at making it undetectable in the blood by standard testing. Published in the Jan. 27 issue of Nature, a new...
New Scientist, 16 November 2015
It could be just what HIV researchers the world over have been waiting for – a non-toxic drug that will drive the virus from its hiding places around the body. What is it? The well-known anti-alcohol drug, Antabuse.
Read more here
Kirby Institute, 3 July 2015
In a new study from the Kirby Institute at UNSW Australia, researchers have found that HIV cells in the body of a person receiving antiretroviral treatment become activated 24 times less frequently than previously thought.
Read more here